Below are the most recent publications written about "National Institutes of Health (U.S.)" by people in Profiles.
-
Psotka MA, Abraham WT, Fiuzat M, Filippatos G, Lindenfeld J, Ahmad T, Felker GM, Jacob R, Kitzman DW, Leifer ES, Lewis EF, Mentz RJ, Nkulikiyinka R, Ni W, Schaber DE, Sharma A, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Whellan DJ, Wittes J, Anker SD, O'Connor CM. Functional and Symptomatic Clinical?Trial?Endpoints: The HFC-ARC Scientific Expert Panel. JACC Heart Fail. 2022 12; 10(12):889-901.
-
Makhni EC, Meadows M, Hamamoto JT, Higgins JD, Romeo AA, Verma NN. Patient Reported Outcomes Measurement Information System (PROMIS) in the upper extremity: the future of outcomes reporting? J Shoulder Elbow Surg. 2017 Feb; 26(2):352-357.
-
Bell TM, Valsangkar N, Joshi M, Mayo J, Blanton C, Zimmers TA, Torbeck L, Koniaris LG. The Role of PhD Faculty in Advancing Research in Departments of Surgery. Ann Surg. 2017 Jan; 265(1):111-115.
-
Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O'Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol. 2014 Jan 10; 32(2):129-60.
-
Constantinescu R, Elm J, Auinger P, Sharma S, Augustine EF, Khadim L, Kieburtz K. Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial. Mov Disord. 2014 Feb; 29(2):263-5.
-
Dembe AE, Lynch MS, Gugiu PC, Jackson RD. The translational research impact scale: development, construct validity, and reliability testing. Eval Health Prof. 2014 Mar; 37(1):50-70.
-
Uitto J, Rodeck U. Integration of investigative dermatology into the global biomedical research enterprise: past, present, and future. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):1029-32.
-
Waldman SA, Terzic A. Clinical pharmacology at the core of translational science. Expert Rev Clin Pharmacol. 2011 May; 4(3):303-5.
-
Waldman SA, Terzic A. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise. Clin Transl Sci. 2011 Feb; 4(1):69-71.
-
Fitzpatrick AM, Teague WG, Meyers DA, Peters SP, Li X, Li H, Wenzel SE, Aujla S, Castro M, Bacharier LB, Gaston BM, Bleecker ER, Moore WC. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol. 2011 Feb; 127(2):382-389.e1-13.